CAT-03-106

N/A

Report date: 2025/01/26 19:11:53

Base Information

Drug NameCAT-03-106

Drug Alias NameAntibody-drug conjugate (Catalent Biologics)CAT-03-106

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionMicrotubule inhibitors

TargetsUpdating

Therapy Area/IndicationsLymphoma, Non-HodgkinHodgkin DiseaseLeukemia, Myeloid, Acute

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCatalent Inc

China Registration ClassN/A

Develop Information

Active CompaniesCatalent Inc

Inactive CompaniesN/A

Active IndicationsLymphoma, Non-HodgkinHodgkin DiseaseLeukemia, Myeloid, Acute

Inactive IndicationsN/A

Other Information

ATC CodeN/A